Your search returned 3 results.

Results
	1.	Non-Inferiority of Once-Daily Cobicistat-Boosted Darunavir Versus Ritonavir-Boosted Darunavir in Hiv-1-infected Adult Patients: An Adjusted Comparative Analysis of Pooled Phase 3 Data. [electronic resource] by Van Sanden, S Thilakarathne, P Opsomer, M Mrus, J Vanveggel, S Lathouwers, E Adriaenssen, I Producer: 20160610 In: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Subgroup analysis of virological response rates with once- and twice-daily darunavir/ritonavir in treatment-experienced patients without darunavir resistance-associated mutations in the ODIN trial. [electronic resource] by Sension, M Cahn, P Domingo, P Hodder, S Opsomer, M Lathouwers, E Van de Casteele, T Tomaka, F Producer: 20140109 In: HIV medicine vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Final 192-week efficacy and safety of once-daily darunavir/ritonavir compared with lopinavir/ritonavir in HIV-1-infected treatment-naïve patients in the ARTEMIS trial. [electronic resource] by Orkin, C DeJesus, E Khanlou, H Stoehr, A Supparatpinyo, K Lathouwers, E Lefebvre, E Opsomer, M Van de Casteele, T Tomaka, F Producer: 20130419 In: HIV medicine vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)